Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic Cancer Specimens Collected by Endoscopic Ultrasonography‐Guided Tissue Acquisition

Tumor cell counts ≥ 2300 and total cell counts ≥ 6000 may serve as surrogate criteria for tissue area to determine EUS-TA specimen suitability for CGP in pancreatic cancer. Given that tumor cell count is a more biologically relevant indicator, total cell count should be used as a supplementary indicator.